INmune Bio, Inc. Announces FDA Clearance of IND Application for INKmune(TM), a Natural Killer Therapy, for a Phase I/II Trial in Metastatic Castration-Resistant Prostate Cancer

May 8, 2023

Biotechnology

MAIA Biotechnology Announces $1.00 Million Private Placement

April 23, 2024
Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group

April 23, 2024
Nutriband Inc. Announces $8.4M Private Placement

April 19, 2024
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million

April 18, 2024